McKesson Financials
MCK Stock | USD 620.71 2.91 0.47% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Current Ratio | 1.34 | 1.05 |
|
|
The financial analysis of McKesson is a critical element in measuring its lifeblood. Investors should not minimize McKesson's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Cash And Equivalents |
|
McKesson | Select Account or Indicator |
McKesson Stock Summary
McKesson competes with Cardinal Health, Henry Schein, Patterson Companies, Owens Minor, and EDAP TMS. McKesson Corporation provides healthcare services in the United States and internationally. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas. Mckesson Corp operates under Medical Distribution classification in the United States and is traded on New York Stock Exchange. It employs 58000 people.Foreign Associates | |
Specialization | Health Care, Health Care Equipment & Services |
Instrument | USA Stock View All |
Exchange | New York Stock Exchange |
ISIN | US58155Q1031 |
CUSIP | 58155Q103 581557105 58155P501 |
Location | Texas; U.S.A |
Business Address | 6555 State Highway |
Sector | Health Care Providers & Services |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.mckesson.com |
Phone | 972 446 4800 |
Currency | USD - US Dollar |
McKesson Key Financial Ratios
Profit Margin | 0.01 % | ||||
Operating Margin | 0.01 % | ||||
Price To Sales | 0.23 X | ||||
Revenue | 308.95 B | ||||
Gross Profit | 13.12 B |
McKesson Key Balance Sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 65.0B | 63.3B | 62.3B | 67.4B | 77.6B | 81.4B | |
Other Current Liab | 3.6B | 9.0B | 3.9B | 4.6B | 5.3B | 2.9B | |
Net Debt | 3.1B | 4.0B | 2.6B | 2.8B | 3.2B | 2.2B | |
Retained Earnings | 8.2B | 9.0B | 12.3B | 15.0B | 17.2B | 18.1B | |
Accounts Payable | 39.0B | 38.1B | 42.5B | 47.1B | 54.2B | 56.9B | |
Cash | 6.3B | 3.5B | 4.7B | 4.6B | 5.3B | 5.5B | |
Net Receivables | 19.2B | 18.6B | 19.4B | 21.6B | 24.9B | 26.1B | |
Inventory | 19.2B | 18.7B | 19.7B | 21.1B | 24.3B | 25.5B | |
Other Current Assets | 677M | 5.4B | 513M | 626M | 719.9M | 676.4M | |
Total Liab | 63.6B | 65.1B | 63.8B | 69.0B | 79.4B | 83.4B | |
Total Current Assets | 45.4B | 46.2B | 44.3B | 48.0B | 55.2B | 57.9B | |
Short Term Debt | 1.5B | 1.4B | 1.6B | 640M | 736M | 696.3M | |
Intangible Assets | 2.9B | 2.1B | 2.3B | 2.1B | 2.4B | 2.0B | |
Other Liab | 3.9B | 11.2B | 10.1B | 9.8B | 11.3B | 11.8B | |
Other Assets | 1.9B | 2.6B | 1.3B | 1.8B | 2.0B | 1.7B | |
Long Term Debt | 6.4B | 5.1B | 4.6B | 5.6B | 6.4B | 4.5B | |
Treasury Stock | (8.9B) | (12.9B) | (13.7B) | (17.0B) | (15.3B) | (14.6B) | |
Good Will | 9.5B | 9.5B | 9.9B | 10.1B | 11.7B | 6.9B | |
Net Tangible Assets | (4.4B) | (9.3B) | (12.4B) | (12.7B) | (11.4B) | (10.8B) |
McKesson Key Income Statement Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Interest Expense | 217M | 178M | 248M | 252M | 289.8M | 178.7M | |
Total Revenue | 238.2B | 264.0B | 276.7B | 309.0B | 355.3B | 373.1B | |
Gross Profit | 12.1B | 13.1B | 12.4B | 12.6B | 14.5B | 15.2B | |
Operating Income | 3.5B | 2.9B | 4.4B | 3.9B | 4.5B | 4.7B | |
Ebit | (4.8B) | 2.1B | 4.9B | 4.0B | 4.6B | 4.9B | |
Ebitda | (3.6B) | 3.1B | 5.7B | 4.7B | 5.4B | 5.6B | |
Cost Of Revenue | 226.1B | 250.8B | 264.4B | 296.4B | 340.8B | 357.9B | |
Income Before Tax | (5.0B) | 1.9B | 4.6B | 3.8B | 4.4B | 4.6B | |
Net Income | (4.3B) | 1.1B | 3.6B | 3.0B | 3.5B | 3.6B | |
Income Tax Expense | (695M) | 636M | 905M | 629M | 723.4M | 396.6M | |
Research Development | 74M | 70M | 89M | 179M | 161.1M | 191.4M | |
Non Recurring | 270M | 8.3B | 274M | (8M) | (9.2M) | (8.7M) | |
Minority Interest | 199M | (173M) | 162M | (158M) | (142.2M) | (135.1M) | |
Tax Provision | (695M) | 636M | 905M | 629M | 566.1M | 410.6M | |
Extraordinary Items | (6M) | (1M) | (5M) | (3M) | (3.5M) | (3.3M) | |
Interest Income | 217M | 10M | 248M | 118M | 106.2M | 98.8M | |
Net Interest Income | (217M) | (178M) | (248M) | (134M) | (154.1M) | (161.8M) |
McKesson Key Cash Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Change To Inventory | (2.3B) | (1.2B) | (1.3B) | (1.3B) | (1.2B) | (1.1B) | |
Change In Cash | 2.4B | (2.5B) | 743M | (94M) | (108.1M) | (102.7M) | |
Free Cash Flow | 3.9B | 3.9B | 4.6B | 3.6B | 4.2B | 4.4B | |
Depreciation | 887M | 760M | 608M | 635M | 730.3M | 533.6M | |
Other Non Cash Items | 484M | 2.3B | 465M | 1.3B | 1.5B | 1.6B | |
Dividends Paid | 294M | 276M | 277M | (314M) | (361.1M) | (343.0M) | |
Capital Expenditures | 641M | 535M | 558M | 687M | 790.1M | 444.8M | |
Net Income | (4.3B) | 1.3B | 3.7B | 3.0B | 3.5B | 3.6B | |
End Period Cash Flow | 6.4B | 3.9B | 4.7B | 4.6B | 5.3B | 5.5B | |
Change To Netincome | 193M | (525M) | 2.1B | 140M | 161M | 153.0M | |
Change Receivables | (2.5B) | 1.1B | (1.8B) | (1.1B) | (973.8M) | (1.0B) | |
Net Borrowings | (298M) | (540M) | (1.3B) | (277M) | (249.3M) | (236.8M) | |
Investments | 400M | (89M) | (542M) | (1.1B) | (1.2B) | (1.3B) |
McKesson Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining McKesson's current stock value. Our valuation model uses many indicators to compare McKesson value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across McKesson competition to find correlations between indicators driving McKesson's intrinsic value. More Info.McKesson is regarded second in return on asset category among its peers. It is regarded fourth in profit margin category among its peers fabricating about 0.16 of Profit Margin per Return On Asset. The ratio of Return On Asset to Profit Margin for McKesson is roughly 6.39 . At this time, McKesson's Net Profit Margin is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value McKesson by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.McKesson Systematic Risk
McKesson's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. McKesson volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on McKesson correlated with the market. If Beta is less than 0 McKesson generally moves in the opposite direction as compared to the market. If McKesson Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one McKesson is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of McKesson is generally in the same direction as the market. If Beta > 1 McKesson moves generally in the same direction as, but more than the movement of the benchmark.
McKesson Thematic Clasifications
McKesson is part of several thematic ideas from Wholesale to Obamacare Repeal. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasToday, most investors in McKesson Stock are looking for potential investment opportunities by analyzing not only static indicators but also various McKesson's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of McKesson growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
McKesson February 27, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of McKesson help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of McKesson. We use our internally-developed statistical techniques to arrive at the intrinsic value of McKesson based on widely used predictive technical indicators. In general, we focus on analyzing McKesson Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build McKesson's daily price indicators and compare them against related drivers.
Downside Deviation | 1.1 | |||
Information Ratio | 0.0208 | |||
Maximum Drawdown | 4.71 | |||
Value At Risk | (1.63) | |||
Potential Upside | 2.01 |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in McKesson. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy McKesson Stock please use our How to buy in McKesson Stock guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of McKesson. If investors know McKesson will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about McKesson listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.572 | Dividend Share 2.66 | Earnings Share 21.7 | Revenue Per Share | Quarterly Revenue Growth 0.178 |
The market value of McKesson is measured differently than its book value, which is the value of McKesson that is recorded on the company's balance sheet. Investors also form their own opinion of McKesson's value that differs from its market value or its book value, called intrinsic value, which is McKesson's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because McKesson's market value can be influenced by many factors that don't directly affect McKesson's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between McKesson's value and its price as these two are different measures arrived at by different means. Investors typically determine if McKesson is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, McKesson's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.